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ABSTRACT 
In the mammalian nervous system, synaptic transmission relies on coordinated coupling 
of synaptic vesicle (SV) exocytosis and endocytosis. While much attention has focused 
on characterizing the proteins involved in SV recycling, the roles of membrane lipids and 
their metabolism remain poorly understood. Diacylglycerol, a major signaling lipid 
produced at synapses during synaptic transmission, is regulated by diacylglycerol kinase 
(DGK). Of the ten known mammalian DGK isoforms, DGKθ is one of the least studied 
DGK isoforms found in the brain with no known function to date. The goal of this study 
aimed to identify and characterize the function of DGKθ in the mammalian CNS. 
This thesis describes the first functional role for DGKθ in the mammalian central nervous 
system in facilitating recycling of presynaptic vesicles at excitatory synapses. Using an 
optical reporter, we found that acute and chronic deletion of DGKθ attenuated the 
recovery of SVs following neuronal stimulation. Rescue of recycling kinetics required 
DGKθ kinase activity. Our data establish a role for DGK catalytic activity and its 
byproduct, phosphatidic acid, at the presynaptic nerve terminal in facilitating SV 
recycling. Together these data suggest DGKθ supports synaptic transmission during 
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Basic brain function depends on communication between neurons. The process of 
sending a message from one neuron to its neighbor occurs at specialized sites, called 
synapses. The arrival of an action potential to the presynaptic nerve terminal initiates this 
communication process by stimulating the release of neurotransmitter-filled SVs from the 
presynaptic terminal. The neurotransmitters then travel across the synaptic cleft where 
they bind to and activate receptors in the postsynaptic membrane, thereby initiating a new 
signaling cascade to propagate the message into the neighboring neuron. Understanding 
the molecular mechanisms that regulate this communication, which, in turn, dictate 
higher brain function, is critical for understanding nervous system function in health and 
disease.  
Despite making up half of the dry weight of the human brain, membrane lipids 
have only recently begun to emerge as important modulators of neuronal function(1). 
Initially thought of as structural building blocks of membranes or high energy sources of 
cellular fuel, several studies have now identified many important signaling roles for 
membrane lipids in basic synaptic function as well as neurological disorders(2-4). Like 
other soluble second messengers, signaling lipids are maintained at very low 
concentrations in a resting cell. Since the availability and abundance of signaling lipids is 
dictated by the enzymes that mediate their generation and metabolism in membranes, 
lipid metabolizing enzymes are not surprisingly emerging as important regulators of 
neuronal function(3, 5). While we are still at the early stages of understanding the 
neuronal functions of membrane lipids and their metabolic enzymes, much of what we 
know comes from studies examining how these molecules regulate the important synaptic 
vesicle cycle. 
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1.1 Synaptic transmission and the synaptic vesicle cycle 
The ability of neuronal cells to transmit information rapidly and reliably is critical 
for the proper function of the nervous system (6). This is achieved in part through the 
synaptic vesicle (SV) cycle, a tightly regulated process that efficiently recycles and 
reuses SVs during neuronal firing (Figure 1.1) (7, 8). The cycle is initiated by the arrival 
of an action potential to the presynaptic terminal, which triggers Ca2+-mediated fusion of 
SVs with the plasma membrane (exocytosis) and release of neurotransmitters into the 
synaptic cleft. SVs are then taken back up into the nerve terminal via endocytosis, refilled 
with neurotransmitters and recycled for another round of release.  
The efficiency of neurotransmission is in part defined by the limited supply of 
100-300 SVs available within each nerve terminal (8, 9). De novo synthesis of SV can 
take upwards of hours to days for a new SV made in the cell soma to reach the synapse, a 
process far too slow to sustain neurotransmitter release and transmission, which occurs 
several orders of magnitude faster (milliseconds to minutes) (10). Therefore, neurons rely 
on local recycling of SVs within the bouton to maintain neurotransmission. This becomes 
particularly critical during periods of elevated neuronal activity, where multiple SVs fuse 
with the membrane over a short period of time (11). SV recycling is essential for 
neuronal function, and its dysregulation may contribute to several neurological and 
psychiatric disorders (8, 12).  
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Figure 1.1 The synaptic vesicle cycle. Schematic of the basic steps of the synaptic 
vesicle (SV) cycle at central nerve terminals. The cycle begins with the arrival of an 
action potential to the presynaptic nerve terminal. Depolarization of the presynaptic 
membrane opens voltage-gated Ca2+ channels. The resulting influx of Ca2+ ions triggers 
exocytosis of SVs and release of neurotransmitters (red) into the synaptic cleft, where 
they to bind receptors on the postsynaptic membrane and propagate the signal 
(postsynaptic membrane not shown). The SV membrane is then recovered from the 
plasma membrane via endocytosis, reacidified and filled with neurotransmitters, and 
recycled back to either the recycling pool of vesicles or the membrane fore another round 
of release. Figure modified from (13, 14) 
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Despite being one of the most well-studied cellular processes, the mechanisms 
that mediate the steps of the SV cycle, particularly those involved in endocytosis, remain 
a matter of debate. To date, four mechanisms of SV endocytosis have been described: (1) 
clathrin-mediated endocytosis (CME), (2) activity-dependent bulk endocytosis (ADBE) 
(11), (3) kiss-and-run(13), (4) and most recently ultra-fast-endocytosis(15). These 
pathways are differentially utilized depending on the strength and duration of neuronal 
activity, as well as their molecular machinery, speed and capacity for membrane retrieval. 
For the purpose of this thesis, CME and ADBE, are the most well understood pathways 
that predominant SV endocytosis during mild or strong neuronal firing, respectively, and 


























Figure 1.2 Predominant mechanisms of SV recycling. (A) Clathrin-mediated 
endocytosis, the dominant mechanism for vesicle retrieval during mild neuronal activity, 
occurs on the scale of 10-30s. Following complete fusion of the SV with the plasma 
membrane, SV membrane and protein components are recovered directly from the 
plasma membrane via formation of clathrin coated vesicles. These vesicles are then 
pinched off from the membrane by the action of dynamin, uncoated, and then refilled 
with neurotransmitters, and trafficked to the recycling pool of SVs or back to the 
membrane. (B) Activity-dependent bulk endocytosis is dominant mechanism of SV 
endocytosis during elevated neuronal activity. This mechanism involves retrieval of large 
areas of synaptic membrane (bulk endocytic structures). SVs then bud off from the 
endosome, via clathrin-dependent and clathrin-independent mechanisms. Figure modified 
from (10).  
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1.2 Role for lipids in neurotransmission 
In the SV cycle, exocytosis of vesicles is tightly linked with endocytosis, and 
variations in the number of vesicles and/or defects in the refilling of vesicles will affect 
the amount of neurotransmitter available for release (13). While previous studies outlined 
an array of proteins involved in the SV cycle, the lipid composition of presynaptic 
membranes also plays an active role in the regulation of synaptic vesicle recycling (7, 17, 
18). However, the enzymes involved in lipid metabolism that is important for regulating 
vesicle recycling are not well understood (2, 3, 5). 
Of the membrane lipids that have been studied, phosphoinositides have the most 
well established role in this cycle (2, 3). Phosphatidylinositol-4,5-bisphosphate 
(PtdIns(4,5)P2), modulates both SV exo- and endocytosis by recruiting and activating 
proteins required for theses pathways (e.g. synaptotagmin I (2, 19), clathrin adaptor 
proteins AP2 and dynamin-1 (7, 20, 21)) to the presynaptic membrane. The emerging role 
of PtdIns(4,5)P2 in the regulation of the SV cycle inherently implicates the enzymes that 
control the abundance of this lipid in synaptic membranes. Consistent with this notion, 
genetic deletion of the lipid kinase (phosphatidylinositol phosphate kinase type Iγ, 
PIPK1γ) (7), or phosphatase (synaptojanin 1) (17, 18) that mediate the generation and 
metabolism of PtdIns(4,5)P2 respectively, resulted in multiple synaptic defects, including 
impaired SV recycling kinetics. In addition to a role for the intact PtdIns(4,5)P2, 
metabolism of this lipid via a phospholipase C to generate diacylglycerol (DAG) is also 
implicated in synaptic function (7, 22). DAG may play at least three roles in the SV 
cycle. First, DAG binds Munc13-1and mediates its role in the priming of SVs for 
exocytosis, a function that is absolutely required for SV fusion during spontaneous and 
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evoked synaptic transmission (23-26). Second, DAG activates PKC, which 
phosphorylates and thereby regulates the activities of presynaptic SNARE complex 
proteins (Munc-18, SNAP-25) (7, 27, 28). Finally, termination of DAG signaling through 
its phosphorylation by DAG kinases (DGKs) results in the production of phosphatidic 
acid (PtdOH), an acidic phospholipid which can act as a signaling molecule itself as well 


















Figure 1.3 Lipid regulation of the synaptic vesicle cycle Top, electron micrograph of 
hippocampal CA1 synapse showing the presynaptic membrane and the lipid bilayer 
(arrow). Middle, detailed schematic of the SV cycle shown in Figure 1.1, highlighting the 
steps where the lipids are known to play regulatory roles. Bottom, lipid kinases (PIPK1γ, 
DGK), phosphatases (synaptojanin), and lipases (PLC), regulate the levels of PtdIns (PI 
lipids), DAG, and PtdOH. Figure modified from (10). 
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1.3 Diacylglycerol kinases 
DGKs constitute a large family of lipid kinases that are abundant in CNS (22, 29). 
The fact that all ten DGK isoforms (α, β, γ, δ, ε, ζ, η, θ, ι and κ) are expressed in the 
mammalian brain lends strong support for the concept that these enzymes are required to 
support brain function. Indeed, several functional studies have implicated individual 
DGK isoforms in modulating spine dynamics, SV release probability, neuronal plasticity 
and neurological disorders (β, ζ, ι, ε, η) (32-36). However, at present there are no reports 
that examine the cellular function of DGKθ in the mammalian central nervous system. 
Given the importance of PtdIns(4,5)P2-DAG mediated signaling at presynaptic terminals, 
and the fact that the C. elegans DGK-1, an ortholog of DGKθ, modulates 
neurotransmitter release (37), we hypothesized that DGKθ may have an important role in 
controlling SV recycling. 
The data presented in the study presented in this thesis show DGKθ plays an 
important role in modulating SV recycling in mammalian cortical neurons. Both shRNA-
mediated knockdown of DGKθ and neurons derived from DGKθ knock-out mice exhibit 
a decreased rate of synaptic vesicle endocytosis compared to control neurons. 
Importantly, this defect in SV recycling is rescued by ectopic expression of enzymatically 
active DGKθ, but not a kinase-dead enzyme. Our data are the first to establish a role for 
DGKθ kinase activity in the regulation of SV recycling, and suggest that DGKθ supports 










CHAPTER 2.  




Wild-type (WT) and DGKθ knock-out (KO) mice used for this research were made from 
heterozygous Dgkqtm1a(KOMP)Wtsi generated by the trans-NIH Knock-Out Mouse Project 
(KOMP) and obtained from the KOMP Repository (www.komp.org). NIH grants to 
Velocigene at Regeneron Inc. (U01HG004085) and the CSD Consortium 
(U01HG004080) funded the generation of gene-targeted ES cells for 8500 genes in the 
KOMP Program and archived and distributed by the KOMP Repository at UC Davis and 
CHORI (U42RR024244). For more information or to obtain KOMP products go to 
www.komp.org or email service@komp.org. Sprague Dawley rats were used for E18 
hippocampal and cortical cultures. All animals were treated in accordance with the Johns 




Imaging reagents: TTX, DL-AP5, and CNQX (Tocris), were resuspended with water to 
make 1000x stock solutions (1 mM, 50 mM, 10 mM, respectively), aliquots were stored 
at -20°C until use. Bafilomycin A1 (Calbiochem) was resuspended in DMSO to make 
1mM stock solution, aliquots were stored at -20°C until use. Antibodies: mouse anti-
DGKθ, DGKι, DGKγ from BD biosciences, chicken anti-MAP2 (Novus), mouse anti-
PSD-95 (NeuroMab), guinea pig anti-vGlut1 (Synaptic systems), mouse β-Tubulin 
(Sigma), rabbit anti-GluR1 (RLH lab), rabbit anti-dsRed (Clontech), chicken anti-GFP 
(Abcam). IRDye-conjugated secondary antibodies were used for infrared imaging 
(Odyssey; LICOR). 
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2.3 DNA constructs (Molecular Biology) 
shRNA-knockdown and rescue plasmids. Complementary primers containing DGKθ or 
control shRNA (Ctrl) sequences were annealed and cloned into SacI and XhoI sites of 
pSuper vector and driven by H1 RNA polymerase III promoter. Ctrl shRNA sequence 
was specific for luciferase. shRNA targeting sequences: DGKθ-shRNA (38), 5'- 
GTGTACATTTGGACGTCTA -3'; luciferase shRNA, 5'- 
CGCTGAGTACTTCGAAATGTC -3'. For rescue experiments, human DGKθ or DGKθ-
kinase dead (DGKθ-kd, point-mutation G648A in kinase domain (39)) was subcloned 
into pRK5-Myc between SalI and NotI restriction sites and driven by CMV promoter 
(MycDGKθ and MycDGKθ-kd, respectively). Other DNA plasmids used: synaptophysin-
pHluorin (CMV::SypHy A4) was obtained from Addgene (plasmid 24478). 
 
2.4 Lentivirus 
Control and DGKθ-shRNA were subcloned into FuGW lentiviral vector and lentivirus 
was produced as described previously(40). Briefly, HEK 293 cells were transfected with 
FuGW, d8.9, VSV-G, using lipofectamine 2000. Cells were treated with sodium butyrate 
18hrs post-transfection, Virus was collected 8hrs, and 24hrs post treatment. Virus was 
concentrated, and resuspended in NB, aliquots were frozen and stored at -80C. 
 
2.5 Neuronal Cell Culture  
Cortical neurons from E18 rat pups were plated onto poly-L-lysine coated dishes or 
18mm coverslips in Neurobasal growth medium supplemented with 2%B27, 2 mM 
Glutamax, 50 U/mL penicillin, 50 μg/mL streptomycin, and 5% Horse serum. After 3-4 
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days in vitro (DIV) neurons were treated with FDU diluted into growth medium 
supplemented as above but with 1% horse serum. Neurons were then maintained in glial-
conditioned growth medium (1% serum) and fed twice a week. Mouse neuronal cultures 
were prepared as described about from age-matched E16-E18 WT and homozygous 
DGKθ KO pups.  
 
2.6 Determination of DGKθ half-life 
Cyclohexamide (20 mg/mL) was added to N2a and 3T3 cells 24 h after cells were seeded 
in 12W plates. Cells were collected at 0, 2, 4, 6, 24, 48, and 72 h and whole-cell lysates 
were prepared for western blotting analysis. The relative amount of DGKθ protein was 
determined with densitometry (Odyssey infrared systems, LiCor Biosciences) and 
normalized to α-GAPDH or α-tubulin. Curve fitting was done using Prism 5 software 
(GraphPad Software, San Diego CA). 
 
2.7 Glutamate release assay.  
For these experiments, rat cortical neurons were infected on DIV 8 with lentiviral 
particles containing either control or DGKθ-shRNA. ~1 week later (DIV 14-15) cells 
were assayed for extracellular glutamate release following depolarization with high K+ 
buffer. Briefly, cells were washed two times with ACSF (122.5 mM NaCl, 2.5 mM KCl, 
2 mM CaCl2, 2 mM MgCl2, 30 mM D-glucose, 25 mM Hepes, pH 7.4) and then 
depolarized for 1 m with 90 mM KCl (ACSF with 90 mM KCl, 35 mM NaCl). Samples 
were removed after 10, 20 and 60 s of stimulation and extracellular glutamate was 
quantitated using the Amplex Red glutamate oxidase assay (Invitrogen) as described by 
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the manufacturer.  After each experiment, neurons were harvested in lysis buffer and 
lysates were analyzed by western blot to determine knockdown efficiency. 1 μM 
tetrodotoxin (TTX) and 100 μM TBOA was included in ACSF and 90 mM KCl buffers.  
 
2.9 Synaptic vesicle recycling assay with synaptophysin-pHluorin 
Transfection. Neurons were transfected DIV 8-11 using lipofectamine 2000 (Invitrogen) 
and sypHy live-cell imaging was performed DIV 14-20. Concentration of DNAs used are 
as follows: 1 μg sypHy, 0.4 μg mCherry, 0.2 μg empty vector (pRK5-Myc) or MycDGKθ, 
or MycDGKθ –kd; for shRNA-knockdown 1 μg of control (shLuc) or DGKθ-specific 
shRNA (shLuc and sh#1, respectively) was also included. 
 
Live-cell imaging. Coverslips containing neurons were mounted into a custom-built 
perfusion and stimulation chamber which held at 37°C on the heated microscope stage. 
Healthy, transfected neurons were identified by mCherry expression. During image 
acquisition, cells were continuously perfused at 0.5-1.0 mL/min with ACSF. Neurons 
were imaged through a 40x, oil objective (N.A= 1.6x) using a Zeiss spinning-disk 
confocal microscope. Fluorescence was imaged at 488 nm excitation and collected 
through a 505-550 nm filter and mCherry signal was imaged at 561 nm excitation and 
575-615 nm emission. Images were acquired at a rate of 1 frame per 2 seconds. For KCl 
stimulation, 1 μM TTX was included in ACSF and high K+ buffer (ACSF with 50 mM 
KCl, 75 mM NaCl). Cells were perfused for 30 seconds with ACSF to obtain a baseline 
recording, then switched to high K+ buffer for 1 minute, and returned to ACSF for the 
reminder of imaging. For field stimulation, 10uM 6-cyano-7-nitroquinoxaline-2,3-dione 
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(CNQX) and 50uM D,L-2amino-5-phosphonovaleric acid (AP5) were included in the 
recording buffer instead of TTX. Action potentials were evoked at 10 or 50 Hz (100 mA, 
1 ms pulse width, delivered using platinum wires embedded in the imaging chamber). 




Neurons were rinsed with PBS and fixed for 15 minutes at room temperature in PBS 
containing 4% paraformaldehyde (PFA) and 4% sucrose. Cells were washed 3 times and 
permeabilized with 0.25%TX-100 in PBS for 10 minutes. Neurons were then blocked 
with 10% BSA serum in PBS for 1hr at 37oC and incubated in primary antibodies in PBS 
containing 3% BSA at room temperature. Neurons were washed 5 times before they were 
incubated with fluorescently labeled secondary antibodies (goat conjugated Alexafluor 
647, 568, or 488). Following 5 final washes with PBS, coverslips and mounted onto glass 
slides using Fluoromount-G (Southern Biotech). Images were obtained using a 510-laser 
scanning confocal microscope (Zeiss). 
 
2.11 DGK activity assay 
Assay was performed as described previously (41). Large unilamellar vesicles were 
prepared on the day of assay as follows: stock lipids were combined, dried under nitrogen 
and stored under vacuum at 4° C for 2-20 hours to remove residual CHCl3. Lipid films 
were rehydrated in DGK assay buffer (55 mM Hepes, 100 mM NaCl) for 30 min at 40°C 
with occasional vortexing and sonication (30 seconds, Branson Sonicator). Vesicles were 
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formed at 37-40C by extrusion through a 0.1µm polycarbonate membrane using an 
Avanti mini extruder per manufacturer instructions. Lipid composition was 
POPC:POPE:POPS:DOG at mole fractions of 26:51:15:8, respectively. 5μg of S1 
fractions were added to the vesicles and reactions were incubated 30 min at 37C without 
agitation. The final assay contained: 1.2 mM total lipid in 50 mM Hepes pH 7.5, 1 mM 
DTT, 1.5 mM MgCl2, 1 mM [γ32 P]ATP (specific activity = 2.5x105 cpm/nmol ATP). 
Reactions were terminated by addition of chloroform/methanol/1M NaCl (1:2:0.8) (v:v), 
and phases separated by addition of 1 ml each of CHCl3 and 1M NaCl. The organic phase 
was washed with 2 ml of 1M NaCl, dried under nitrogen gas, resuspended in 
CHCl3:MeOH (95:5) and spotted onto a silica gel 60 TLC plate. Phosphatidic acid 
(PtdOH) was separated from other lipids with chloroform:acetone:methanol:acetic 
acid:water (10:4:3:2:1) (v:v). The amount of [γ32P]PtdOH was measured by liquid 
scintillation spectrophotometry in a Wallac 1410 liquid scintillation counter. DGK 
activity was quantified as nmol PtdOH min-1 μg -1 of protein. Assay conditions used in 
these experiments are routinely used to measure DGK activity of purified forms of 
DGKθ, DGKζ, and DGKδ (personal communication from Becky Tu-Sekine). By 
excluding calcium from the DGK assay buffer, we minimized activity measured in cell 
fraction from the type I DGK isoforms (α, β, and γ). 
 
2.12 PSD preparation 
Forebrain or whole brain was isolated from adult mouse and frozen on dry ice. Brain was 
thawed in homogenization buffer (320 mM sucrose, 5 mM sodium pyrophosphate, 1 mM 
EDTA, 10 mM HEPES pH 7.4, 200 nM okadaic acid, protease inhibitor cocktail 
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(Roche)) and homogenized 30 times in glass homogenizer. The homogenate was 
centrifuged at 800xg for 10 minutes at 4oC to yield P1 and S1. S1 was further centrifuged 
at 10,000xg for 20 minutes at 4oC to yield P2 and S2. P2 was layered on top of a sucrose 
gradient composed of 0.8, 1, 1.2 mM sucrose buffers, respectively, containing protease 
and phosphatase inhibitors. The gradient was centrifuged 82,500 xg for 2hrs at 4oC . The 
layer containing synaptosomes (between 1 and 1.2mM sucrose) was isolated, diluted with 
10mM Hepes buffer, pH 7.4, and synaptosomes were pelleted by centrifugation at 
150,000 x g for 30 minutes at 4oC. Synaptosomal pellet (SYN) was resuspended in 
50mM HEPES pH 7.4, mixed with an equal volume of 1% triton X-100, and incubated 
with agitation at 4oC for 15 minutes. The PSD was generated by centrifugation at 
32,000xg for 20 minutes at 4oC. The final PSD pellet was resuspended in 50mM HEPES 
pH 7.4 followed by protein quantification and western blot.  
 
2.13 Electron microscopy 
These experiments were done in collaboration with Michael Delannoy and the Johns 
Hopkins University School of Medicine Microscope Facility 
(http://www.hopkinsmedicine.org/micfac/) and Dr. Shu-Ling Chiu, a postdoctoral fellow 
in the Huganir lab. M.D. performed post-fixation processing of samples, S.H.C. perfused 
mice for hippocampal sections.  H.L.G performed imaging acquisition and analysis.  For 
analysis of synapses in hippocampal CA1 neurons, age-matched DGKθ WT and KO mice 
(6mo old) were anesthetized with avertin (0.03ml/g) then perfused with phosphate buffer 
(PB, 37°C see recipe below) followed by ~100 mL of the fixative solution (2.0% 
glutaraldehyde, 2.0% paraformaldehyde (freshly prepared form EM grade prill form), 
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100 mM sodium cacodylate and 3 mM MgCl2, pH 7.4 at 4°C). Animals were perfused at 
~7-8 mL/min. Brain tissue was removed and fixed in the same solution overnight at 4°C. 
1 mm thick coronal sections that contained the hippocampal CA1 were cut down to 3 
mm3 pieces for further processing. Following buffer rinse containing 3% sucrose, 
samples were post-fixed in 1.5% potassium ferrocyanide (K4Fe(CN)6) reduced 2% 
osmium tetroxide (OsO4) in 100mM sodium cacodylate with 3 mM MgCl2 for 2 h on ice 
in the dark.  After a brief rinse in 100 mM Maleate buffer containing 3% sucrose, tissue 
sections were placed in 2% uranyl acetate in maleate/sucrose (0.22 μm filtered) for 1 h at 
4°C with slow rocking in the dark.  Following en-bloc staining cells were dehydrated 
through a graded series of ethanol, transferred through propylene oxide and were 
embedded in Eponate 12 (Pella) and cured at 60°C for two days. Sections were cut on a 
Riechert Ultracut E with a Diatome Diamond knife.  80 nm sections were picked up on 
formvar coated 1 x 2 mm copper slot grids and stained with uranyl acetate followed by 
lead citrate.  Grids were viewed on a Hitachi 7600 TEM operating at 80 kV and digital 
images captured with an XR50, 5 megapixel CCD camera (AMT). 
WT and DGKθ KO neurons grown on 18mm coverslips were transferred to 35 
mm tissue culture dishes (Falcon 3001) and rinsed two times with warm ACSF (37°C), 
then fixed with 1.3% glutaraldehyde in 66 mM sodium cacodylate containing 3 mM 
CaCl2 pH 7.2 (~300 mOsmols) for 1 hr. at room temperature on a slow rocker.  After a 30 
min buffer rinse (100 mM sodium cacodylate with 2% sucrose and 3 mM CaCl2), cells 
were post-fixed in 1% OsO4 reduced with 1.5% K4Fe(CN)6 in 100 mM sodium cacodylate 
with 3 mM CaCl2 at 4°C for 2 hrs in the dark.  Samples were then rinsed with dH2O and 
en-bloc stained with 0.5% uranyl acetate (0.22 um filtered, aq.) for 1 hr in the dark.  
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Plates were dehydrated in a graded series of ethanol then infiltrated in Eponate 12 (Pella) 
overnight without catalyst.  The next day cells were further embedded with fresh epon 
containing 1.5% DMP-30 (catalyst).  Culture dishes were cured at 37°C for three days, 
and further polymerized at 60°C overnight.  Cured discs were removed from the plastic 
dish and 3 mm circles punched out and glued to epon blanks for sectioning.  Coverslips 
were placed cell side down onto inverted beam capsules, filled with Epon and cured 
overnight at 60°C.  Once polymerized, coverslips were submerged into liquid nitrogen 
until they separated from the beam capsule and sectioned. 80 nm thin compression free 
sections were obtained with a Diatome diamond knife (35 degree).  Sections were picked 
up onto 1x2 mm formvar coated copper slot grids (Polysciences), and further stained with 
uranyl acetate followed by lead citrate.  Grids were examined on a Hitachi H-7600 TEM 




2.13 DGKθ truncation mutants. 
Truncation mutant cloning. DGKθ truncation cDNAs were made by PCR using primers 
(see below) using human MycDGKθ as a template and Q5 DNA polymerase (NEB 




Insertion Primers fragment 
size (bp) 
T1 Δ566-941 SalI -- NotI sense ATC CAC TTT GCC TTT CTC TCC 
1758 antisense CCG CAC AGC CAT GTC CTT CA 
T2 Δ262-941 SalI -- NotI sense ATC CAC TTT GCC TTT CTC TCC 
846 antisense GCT CTG CGT CTT GCT GAA 
T3 Δ1-489 SalI -- NotI sense GG CAG AGA GCA GGG ATG TAG 
1362 antisense CCC GAT CGA TCC AGA CAT GAT AAG 
T4 Δ1-255 SalI --BsrGI sense CT TCA GCA AGA CGC AGA G 
979 antisense AGC TTC GCG TGC AGC AGG TC 
T5 Δ1-580 SalI -- NotI sense GA AGC TGC CCC CAG ACA GC 
1089 antisense CCC GAT CGA TCC AGA CAT GAT AAG 
T6 Δ1-25 SalI -- AfeI sense CA GCC CCG TGC TGG GCT CA 
837 antisense ATC AAA GAT CTT CAG CGT TTG 
 
PCR conditions: 98°C, 5min; (98°C, 45sec; 65°C, 30sec; 72°C, 2min) x 30 cycles; 72°C, 
10min. Resulting cDNAs were subcloned in frame into pRK5-Myc between SalI and 
NotI (T1, T2, T3, and T5) or SalI and BsrGI (T4) or SalI and AfeI (T6) restriction sites. 





Expression and DGK activity validation of DGKθ truncation constructs 
HEK 293 cells were seeded in 6W dishes (1.8e6 cells/well) in opti-MEM and transfected 
using PEI (4 μg PEI: 1 μg plasmid DNA). 4 μg PEI was diluted into 100 μL opti-MEM 
and incubated for ~5m. 100 μL PEI solution was added to 100 μL of opti-MEM 
containing 2 μg of WT or mutant DGKθ and 0.5 μg pSuper-Venus (cell fill),  and allowed 
to incubate for 20m at room temperature.  200 μLPEI/DNA complexes were added 
dropwise onto cells and incubated for ~4-5h before media was replaced with DMEM 
supplemented with 5%FBS. 3 days after transfection, cells were harvested in lysis buffer 
(25mM Tris-HCl, 100mM NaCl, 2mM EDTA, 2mM EGTA, 1%Tx-100,  pH 7.4) and 
diluted to 1 μg/μL with SDS-sample buffer for western blot analysis (15 μg lysate per 
sample) or diluted to 1.5 μg/μL in lysis buffer and stored in -80°C until assayed for DGK 
activity. 15 μg of cell lysate was analyzed by western blot analysis and 5 μg of lysate was 
used for DGK activity assays.  
 
Neuron expression and activity validation. Primary rat cortical neurons were 
electroporated with 2 μg of WT or mutant DGKθ and 2 μg pCAG-mCherry (cell fill) on 
DIV0 using a Nucleofection apparatus (Amaxa) with a rat neuron nucleofection kit 
(Lonza) according to the manufacturer’s instructions. Cells were harvested DIV 19 with 
lysis buffer and diluted as described above (HEK cells) for western blot analysis and 
DGK activity assays. For localization experiments, rat hippocampal neurons were 
transfected DIV 19 with 0.5 μg WT or mutant DGKθ, 0.5 μg pCAG-mCherry, and 1 μg 




Hippocampal slices were prepared from DGKθ WT and KO mice ranging from 5-6 
weeks in age. Field excitatory postsynaptic potentials (fEPSPs) were evoked at 50 Hz and 
2 Hz with a 125 μm platinum/ iridium concentric bipolar electrode (FHC, Bowdoinham, 
ME) placed in the middle of stratum radiatum of CA1. A 1–2MΩ glass recording 
electrode filled with ACSF was positioned ~200 μm away (orthodromic) from the 
stimulating electrode. Recording ACSF and temperature were identical, with a flow rate 
of ~3mL/min.  Input-output curves were obtained for each slice and responses were set to 
15-20% max for experiments with picrotoxin and ~40% max for experiments without 
picrotoxin. 100 μm AP5 was included in the ACSF for experiments.  When slices were 
recorded in picrotoxin, 100 μm picrotoxin was also added. For the high-frequency train, 
slices were stimulated at with a train of 900 stimuli at 50 Hz.  At the end of the train, 
slices were subjected to a 2 Hz train and then 0.5 Hz train. A custom-made MatLab 
program was just to extract the maximum amplitude and slope for each fEPSP during the 
50 Hz train and recovery. We confirmed some of these values by performing individual 
analysis of responses in ClampFit. For fEPSPs data, experiments are presented 
amplitudes of individual responses normalized to the first response of the 50 Hz train.  
 
Data analysis and statistics  
All plasticity experiments are presented as responses normalized to the average of the 20min 
baseline. 2min averages are presented in graphs for clarity. Representative traces in Figure 
6.6 are from one DGKθ WT and KO slice with PPF values within 0.1 of the average value.  











CHARACTERIZATION OF THE EXPRESSION AND 
LOCALIZATION DGKΘ IN THE BRAIN  
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3.1 DGKθ expression is coincident with synaptogenesis  
DGKθ expression has been detected in multiple regions of the late embryonic (42) 
and adult mouse brain (22, 43), albeit at low cellular and temporal resolution. To date, 
however, there are only a few reports of cellular functions for this isoform in the 
literature (38, 44-46), and none regarding its function in the mammalian brain. In an 
effort to understand the role of DGKθ in brain function, we examined DGKθ expression 
across multiple brain regions from adult mice. Whole-cell extracts prepared from isolated 
brain regions were examined by western blot analysis using an isoform-specific antibody 
that recognizes the c-terminal region of DGKθ protein. DGKθ was detected in all brain 
regions examined, including the cortex and hippocampus (Figure 3.1A), consistent with 
the previously reported mRNA expression pattern (43). To determine whether DGKθ is 
expressed in neurons or astrocytes, we compared DGKθ expression between forebrain 
cell extracts and primary cultures of glia from the same brain region. DGKθ was detected 
in the forebrain, but not in the cultured glial cells (Figure 3.1B), indicating that DGKθ is 
expressed in neuronal cells in the forebrain. 
Next we examined DGKθ expression during development. Brain tissue was 
isolated from mice between postnatal-day 0 (P0) to 25 (P25) and subjected to western 
blotting. DGKθ signal intensity increased 1.8-fold from P5 to P14, and coincided with the 
expression of synaptophysin, an integral SV protein with an established function at 
synapses (Figure 3.1C). A similar increase in DGKθ protein during synapse formation 
and development was also observed in cultured neurons (DIV 7-14, data not shown). 
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Figure 3.1 DGKθ expression is coincident with synaptogenesis.  (A) Whole-cell extracts 
prepared from adult mouse cortex (CTX), hippocampus (HIP), cerebellum (CB), olfactory bulb 
(OB), midbrain (MB) were assayed for DGKθ protein expression by western blot using α-DGKθ; 
α-tubulin was used as a loading control. (B) Whole-cell extracts from primary glial cultures and 
rat whole brain were assayed for DGKθ protein expression by western blot analysis using α-
DGKθ; α-GFAP (glial marker); and α-synaptophysin (neuronal marker). (C) Whole brain lysates 
from mice between postnatal day 0 (P0) and 25 (P25) were assayed for DGKθ protein expression 
by western blot using α-DGKθ; α-synaptophysin, a presynaptic protein, is shown for comparison; 
α-tubulin was used as a loading control.  (D) Biochemical fractionation of adult mouse brain 
reveals DGKθ is distributed in various subcellular compartments. α-synaptophysin and α-PSD-95 
(pre- and postsynaptic proteins, respectively) are shown for comparison and were used as controls 
for successful isolation of synaptic fractions. Post-nuclear supernatant (S1), cytosol after P2 
precipitation (S2), cytosol after LM precipitation (S3), light membranes (LM), crude 
synaptosomes/membranes (P2), synaptosomes (SYN), postsynaptic density (PSD-I), remaining 
soluble fraction after PSD-I precipitation (PSD-I sol). 20 μg of protein were loaded from each 
fraction.  
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3.2 DGKθ localizes to excitatory synapses in the mouse forebrain 
The onset of DGKθ protein expression during synaptogenesis suggested that 
DGKθ might participate in the regulation of synaptic function. To address this, 
subcellular fractions were prepared from adult mouse whole brain and subjected to 
western blot analysis. Similar amounts of DGKθ were detected in cytosolic (S1, S2, S3), 
microsomal (LM), and synaptosomal (P2, SYN) fractions, indicating a general 
distribution among subcellular compartments within the brain (Figure 3.1D). 
Furthermore, DGKθ was detected in both the synaptosome and PSD-1 fractions, 
suggesting its presence at both pre- and postsynaptic sites. 
To verify the biochemical results we examined endogenous DGKθ localization by 
immunofluorescence microscopy. Neurons were co-labeled with antibodies against 
MAP2 and vGlut1 to illuminate dendrites and excitatory synapses, respectively. 
Consistent with fractionation experiments DGKθ, was detected throughout the neuron, 
including the cell soma, MAP2-positive dendrites, and MAP2-negative axons (Figure 
3.2A and 3.2B). Strikingly we found that DGKθ had a punctate distribution along 
dendrites that significantly overlaps with the excitatory presynaptic protein vGlut1 
(Figures 3.2A and 3.2B). When we quantified the overlap between these two signals, we 
found that 62.6±1.4% of DGKθ overlapped with vGlut1 and 56.6±1.5% of vGlut1 
overlapped with DGKθ per μm of dendrite (Figure 3.2C). 
To determine whether DGKθ is also present at inhibitory synapses, we measured 
the signal overlap between DGKθ and VGAT, a marker of inhibitory synapses, on 
MAP2-positive processes. Only 10.0±0.7% of DGKθ overlapped with VGAT per μm of 
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Figure 3.2.  DGKθ localizes to excitatory synapses.  (A-B) Cultured hippocampal neurons 
(DIV 28) were stained with α-DGKθ, α-vGlut1 (excitatory presynaptic protein) or α-VGAT 
(inhibitory synaptic marker) and MAP2 (dendritic protein). Scale bar, 20μm and 5μm (crop 
region). (C) Quantification of the overlap between α-DGKθ and α-vGlut1 and α-DGKθ and α-
VGAT on secondary dendrites identified by MAP2 staining (MAP2-positive processes). 
Averages from a minimum of 3 coverslips (>3 regions per coverslip) per staining condition are 
shown, error bars represent SEM.   
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3.2 Determination of murine DGKθ half-life (47) 
Our first step toward investigating the cellular function(s) of DGKθ in the 
mammalian CNS was to develop a model system where we could manipulate DGKθ 
protein expression using short-hairpin RNAs (shRNA). This provided a suitable 
background perform loss-of-function analysis as well as for evaluating mutant forms of 
this DGKθ. shRNAs knockdown protein expression by targeting the mRNA for 
degradation. Therefore, to successfully perform loss of function analysis, it is necessary 
to determine the protein half-life, to know how long after depletion of mRNA it takes for 
the protein to be degraded. To address this, cyclohexamide (CHX) was used to block all 
new protein synthesis in two different cell lines derived from either mouse embryonic 
fibroblasts (3T3) or adult neuroblasts (Neuro-2a, N2a). Samples were collected at various 
time-points following treatment with CHX and the abundance of DGKθ protein in whole-
cell lysates was quantified by western blotting. We find that the enzyme exhibits a mean 
half-life of approximately 5.1 ± 2.2 h in cultured cells (Figure 3.3). This is consistent 
with the reported mean half-life of cellular proteins(48). 
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Figure 3.3.  Half-life determination of murine DGKθ.  3T3 (A) and N2a (B) cells were treated 
with cyclohexamide (20 mg/mL) to block protein synthesis for 0, 2, 4, 6, 24, 48, and 72 h. To 
quantify the amount of endogenous DGKθ protein remaining in each sample over the time 
course, whole-cell lysates were analyzed by western blot analysis (Odyssey infrared systems, 
LiCor Biosciences) with α-DGKθ and α-GAPDH, a loading control. α-DGKθ signal intensity in 
each sample was normalized to α-GAPDH signal intensity, and then normalized to the 0 h time 









shRNA-MEDIATED KNOCKDOWN OF DGKΘ 
ALTERS EFFICIENT RECYCLING OF SYNAPTIC 
VESICLES  
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DGKθ localization to excitatory synapses suggested a potential role for this 
enzyme in excitatory synaptic transmission. We predicted that reduction of DGKθ protein 
expression would be sufficient to alter synaptic function. To test this, we generated a 
short-hairpin RNA construct directed against endogenous DGKθ mRNA (Figure 4.1A) 
to suppress DGKθ protein expression. Western blot analysis showed that lentiviral-
mediated expression of DGKθ-shRNA in cortical neurons resulted in >90% suppression 
of DGKθ protein compared to control shRNA-infected cells (Figure 4.1A). 
 
4.1 Knockdown of DGKθ attenuates glutamate  
Since the original study of DGK-1 in C. elegans, many groups have speculated 
that mammalian DGKs may also be involved in the regulation neurotransmitter release 
from synapses within the CNS (22, 37). Our data showing that DGKθ is present at 
excitatory synapses led us to speculate that DGKθ may regulate the release of glutamate, 
the major excitatory neurotransmitter, from cortical neurons. We hypothesized that 
depletion of DGKθ protein from neurons would phenocopy loss of function mutations in 
DGK-1, and accelerate glutamate release. To test this, neurons expressing DGKθ-shRNA 
or a control shRNA were stimulated by high potassium (K+)-induced depolarization. The 
concentration of glutamate released into the extracellular buffer was assayed at various 
time points during the 1 minute stimulation. Consistent with our original hypothesis, we 
observed DGKθ-depleted neurons showed elevated glutamate levels after 10 seconds of 
stimulation when compared to controls (Figure 4.1B). Surprisingly, after either 20 or 60 
seconds of stimulation, DGKθ-depleted neurons released less glutamate when compared 













Figure 4.1. shRNA-knockdown of DGKθ attenuates glutamate release from cortical 
neurons.  (A) Top, schematic of DGKθ protein showing the location of the DGKθ-shRNA target 
relative to the protein domain structure. Bottom, western blot of whole-cell lysates from rat 
cortical neurons expressing either control (Ctrl) or DGKθ-shRNA. α-GAPDH was used as a 
loading control. (B) Neurons expressing either control (Ctrl) or DGKθ-shRNAs were stimulated 
with 90mM KCl for 60 s.  Samples collected from the extracellular media at 10-, 20-, and 60-s 
during stimulation were assayed to determine the concentration of glutamate released using the 
Amplex Red glutamate assay (see Chapter 2.7 for details). 
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4.2 Knockdown of DGKθ slows the rate of synaptic vesicle recycling 
To determine the effect of reduced DGKθ protein levels on presynaptic function, 
we used the pH-sensitive optical reporter synaptophysin-pHluorin (sypHy, Figure 4.2A 
(49)) to monitor SV recycling dynamics. At rest, the fluorescence of sypHy is quenched 
by the low pH inside the SV. Upon depolarization of the nerve terminal, fusion of the SV 
with the membrane exposes the vesicle lumen to the neutral pH of the medium, causing a 
rapid increase in sypHy fluorescence. This is followed by a slow decay of the fluorescent 
signal as the fused vesicles undergo endocytosis and rapid reacidification. Because SV 
endocytosis is rate-limiting in this process (50), the average time constant (τendo) of the 
post-stimulus decay can be mainly attributed to endocytosis. To determine if acute loss of 
DGKθ was sufficient to alter presynaptic function, cortical neurons were co-transfected 
with sypHy and DGKθ-shRNA or a control shRNA, and allowed to express for 48 hours 
prior to measuring SV recycling kinetics. Knockdown of DGKθ produced significantly 
slower reuptake of sypHy or larger τendo values following high potassium (K+)-induced 
depolarization compared to control neurons (Figures 4.2B-4.2C, τ = 59.2 ± 4.2 s and 
32.4 ± 1.9 s, respectively). Moreover, expression of shRNA-resistant human DGKθ 
(mycDGKθ) was sufficient to rescue the observed defect in endocytosis in neurons 
expressing DGKθ-shRNA, thus verifying the specificity of DGKθ-shRNA for the 
endogenous enzyme as well as the requirement for DGKθ in SV recycling (Figures 4.2B-
4.2C). 
Because K+-depolarization is a robust and artificial stimulus, it was important to 
determine whether the observed defect in SV recycling also occurred in response to a 
more physiologic stimulus. To address this, SV recycling kinetics were measured in 
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control and DGKθ-shRNA expressing neurons following electrical field stimulation at 10 
Hz. Consistent with K+-induced depolarization, the average τendo values measured 
following a 30 s stimulation at this frequency (Figures 4.2C-4.2E) were significantly 
slower in DGKθ shRNA expressing neurons compared to controls (τ = 57.0 ± 2.0 s and τ 
= 28.4 ± 0.9 s, respectively). Slower SV recycling kinetics were also observed in DGKθ-
knockdown neurons following a shorter (12 s) stimulation at 50 Hz (Figures 4.3A). In all 
cases, expression of mycDGKθ was able to recover the defect in SV endocytosis kinetics 
(Figures 4.2B-4.2E, 4.3A-4.3B). Taken together, these data show that DGKθ is required 








Figure 4.2.  DGKθ regulates the kinetics of SV recycling in cortical neurons. (A) Schematic 
representation of the optical reporter of SV recycling dynamics, synaptophysin-pHluorin (sypHy, 
modified from(49, 51). SypHy is composed of a pH-sensitive GFP (pKa ~ 7.1) fused to the 
second intravesicular loop of synaptophysin, a resident SV protein. At rest, sypHy fluorescence is 
quenched by the acidic pH inside the vesicle (pH~5.6). Action potential firing stimulates SV 
exocytosis, which exposes the vesicle lumen to the neutral extracellular external solution (pH 
7.4), resulting in a rapid “burst” of fluorescence. The sypHy signal then slowly decays as to 
baseline as the SVs are retrieved from the plasma membrane and reacidified. The rate of 
endocytosis is calculated at individual boutons from the rate of fluorescence decay after 
stimulation. (B) Normalized average traces from rat cortical neurons expressing sypHy in 
response to 1 min stimulation with high K+ buffer. Example traces for control and DGKθ-shRNA 
are shown in black and red, respectively. (C) Comparison of average post-stimulus endocytic 
time constants (τ) between control, DGKθ-shRNA, mycDGKθ (+ctrl shRNA, grey), and mycDGKθ-
rescue (green) neurons. The decay phases of the normalized traces were fitted with single 
exponential functions and the τ values were calculated from the fits. Averages in (B-C) are from 
≥6 coverslips, ≥100 boutons per condition. (D) Example normalized average traces from mouse 
cortical neurons expressing sypHy with control or DGKθ-shRNA (black and red, respectively) in 
response to a 30 s stimulation at 10 Hz. (E) Comparison of average endocytic τ values between 
control, DGKθ-shRNA, mycDGKθ and mycDGKθ-rescue (green) neurons in response to 300 stimuli 
at 10 Hz (from D). Averages in (D-E) are from ≥3 coverslips, >100 boutons per condition. For all 
experiments shown in Figure 4.2, data represent mean ± SEM; *** P<0.001 against Ctrl; ### 
P<0.001 against DGKθ-shRNA, a one-way analysis of variance (ANOVA) with Tukey’s post hoc 
test. The τ values for mycDGKθ and mycDGKθ-rescue and Ctrl and mycDGKθ in (C) and (E) were 











Figure 4.3.  Recycling defect is rescued at synapses by mycDGKθ.  (A) Average post-stimulus 
endocytic time constants are shown for control (Ctrl, black), DGKθ-shRNA (red), mycDGKθ (+ctrl 
shRNA, white) and mycDGKθ-rescue (+DGKθ-shRNA, green) neurons following a 600 stimuli at 
50 Hz. Data represent mean ± SEM; *** P<0.001 against Ctrl; ### P<0.001 against DGKθ-
shRNA, a one-way analysis of variance (ANOVA) with Tukey’s post hoc test. The τ values for 
mycDGKθ and mycDGKθ-rescue were not significantly different. (B) Immunostaining of 
unstimulated mycDGKθ expressing neurons from (A) with α-GFP (sypHy, green) and α-Myc 
(mycDGKθ, blue) antibodies shows significant overlap between the two signals along neuronal 
processes. mycDGKθ colocalization with sypHy indicates mycDGKθ rescues defective SV recycling 








CHAPTER 5.  
 DGKΘ KNOCK-OUT MICE SHOW DEFECTS IN 
SYNAPTIC VESICLE CYCLING AT CENTRAL 
SYNAPSES   
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5.1  DGKθ knock-out mice have reduced synaptic DGK activity 
Since transient depletion of DGKθ was sufficient to alter presynaptic function, we 
wondered if loss of DGKθ during neuronal development would produce a similar 
phenotype. To address this, we generated a conventional DGKθ homozygous knock-out 
(KO) mouse from heterozygous Dgkqtm1a(KOMP)Wtsi (Het) animals (see methods, Figure 
5.1A). The genotypes of wild-type (WT), Het, and KO mice were confirmed by 
conventional PCR with primers targeting the KO allele and by western blot (Figures 
5.1A and 5.1B). DGKθ KO mice appeared overtly healthy and did not display any 
obvious gross morphology difference compared to WT mice (body size, mating, lifespan, 
data not shown). With eight additional DGK isoforms expressed in neuronal tissue, we 
considered the possibility that another DGK isoform may compensate for synaptic 
defects produced by the loss of DGKθ. To address this, we probed whole-cell extracts 
prepared from WT and KO brain tissue antibodies specific for other neuronal DGK 
isoforms. Again, no significant difference in signal intensity was detected between WT 
and KO samples for any of the DGKs examined (-δ, -γ, -ι, and -ζ, Figure 5.1C). Thus, it 
is unlikely that another neuronal DGK isoform is compensating for loss of DGKθ. 
Since all DGK isoforms catalyze the same reaction, phosphorylation of DAG to 
produce PtdOH, another potential mechanism for compensation by other DGKs is 
through their catalytic activity. We measured total DGK activity in cell extracts prepared 
from adult WT and KO forebrain tissue using an in vitro assay has been is used to 
measure activity of purified forms of DGKθ, DGKζ, and DGKδ ((41) and unpublished 
data). Calcium was excluded from the DGK assay buffer to minimized activity from type 
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I DGKs (α, β, γ). Interestingly, loss of DGKθ produced significant decrease in DGK 



















Figure 5.1.  Total DGK activity is reduced in DGKθ KO mice.  (A) Top, schematic of DGKθ 
knock-out mouse allele, Dgkqtm1a(KOMP)Wtsi(52). Exon 1 is spliced to the artificial splice acceptor 
(SA) in front of lacZ instead of another exon in the DGKθ gene. The poly-adenylation site (pA) 
terminates transcription after lacZ, preventing the transcription of the DGKθ RNA. Bottom, 
typical result of PCR for genotyping. Bands at 629bp and 341bp are indicative of wild-type (WT) 
and DGKθ KO alleles, respectively. (B) Western blot analysis of whole-cell lysates prepared 
from brain tissue from 5 week-old WT, DGKθ heterozygous and KO littermates. α-tubulin was 
used as a loading control, α-synaptophysin were used as a marker for brain tissue. (C) Western 
blot analysis of brain tissue isolated from 2 pairs of WT and DGKθ KO mice, run on the same 
gel. Samples were immunoblotted with antibodies against DGKθ, -γ, -ι, -ζ, representing 4 classes 
of DGKs. α-synaptophysin and α-PSD95 are shown for comparison as controls. (D) Average total 
DGK activity measured in 5 μg of S1 cytosolic fractions from 5 pairs of age-matched WT and 
DGKθ KO forebrain tissues (age range from 2 weeks - 6 months). Averages include 3 technical 
replicates per sample, N = 15 (5, 5). Error bars = ± SEM. Student’s t test, *** P<0.0001 against 
WT.  
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5.2  DGKθ catalytic activity is required for kinetically efficient SV recycling 
Because developmental loss of DGKθ produced a significant reduction in DGK 
activity that was not compensated for by other DGKs, we predicted that DGKθ KO 
neurons might exhibit defects in SV recycling similar to those observed in DGKθ-shRNA 
expressing cells (Figure 4). To address this, neurons derived from WT and DGKθ KO 
mice were transiently transfected with sypHy and post-stimulus recovery rates following 
a 50Hz, 600AP stimulus were determined (Figure 5.2A). Consistent with the slower τendo 
values measured in DGKθ-knockdown neurons, we found that DGKθ KO neurons also 
showed significantly larger τendo compared to WT neurons (KO τendo = 63.4 ± 1.3 s vs. 
WT τendo = 23.0 ± 0.8 s) that could be recovered by expression of MycDGKθ (Figure 
5.2A-5.2B). Due to the significant reduction of total DGK activity in DGKθ KO tissue, 
we predicted that the catalytic activity of DGKθ might be necessary for it to promote 
efficient recycling of SVs. Previous work has shown that DGKθ catalytic activity can be 
completely abolished by a single point mutation (G648A) in the conserved ATP binding 
site within the catalytic domain of the enzyme (39). We tested the ability of this kinase-
dead mutant of DGKθ (MycDGKθ-kd) to rescue the defect in SV recycling observed in 
DGKθ KO neurons. Consistent with our hypothesis, expression of MycDGKθ-kd in KO 
neurons was unable to recover the delay in SV recycling kinetics (Figure 5.2B). We 
confirmed that MycDGKθ and MycDGKθ-kd were expressed at similar levels in neurons 
and HEK cells as well as validated the expected DGK activities for both recombinant 
proteins (Figures 5.2C-5.2D, and data not shown). Furthermore, when KO neurons 
expressing MycDGKθ-kd with sypHy were labeled with antibodies against the epitope tags 
(anti-myc and anti-GFP, respectively), we observed significant overlap between the two 
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signals along neuronal processes (Figure 5.2E). The synaptic localization of MycDGKθ-
kd argues that this mutant fails to rescue the SV recycling defect in KO neurons due to its 
loss of catalytic activity, and not mis-targeting of the protein. Taken together, these data 
demonstrate that DGKθ catalytic activity is necessary for efficient recycling of SVs 



























Figure 5.2.  DGKθ activity regulates SV recycling kinetics in vivo.  (A) Normalized average 
traces from wild-type (WT, black) and DGKθ KO (red) neurons expressing sypHy in response to 
600 stimuli at 50 Hz. Averages are from >5 regions per genotype, >3 coverslips, from 3 
experiments (>140 ROIs). (B) Comparison of average post-stimulus (600 AP, 50 Hz) endocytic 
time constants between WT and DGKθ KO neurons expressing empty vector, mycDGKθ, or 
kinase-dead DGKθ (mycDGKθ-kd). All averages in are from ≥3 batches of WT and KO neurons, 
≥3 coverslips, ≥50 boutons per condition; data represent mean ± SEM; *** P< 0.001 against WT; 
### P<0.001 against KO, ANOVA with Tukey’s post hoc test. Average τ values measured in KO 
neurons (+empty vector) were not significantly different from KO + mycDGKθ-kd. (C-D) 
mycDGKθ and mycDGKθ-kd are expressed at similar levels in neurons and exhibit expected DGK 
activities in neuronal lysates. (C) Western blot analysis of whole-cell lysates prepared from 
cortical neurons (DIV 18) electroporated with pRK5, mycDGKθ, or mycDGKθ-kd. α-DGKθ mAb 
was used to compare endogenous DGKθ expression in pRK5 expressing neurons with mycDGKθ 
and mycDGKθ-kd. α-GAPDH was used as a loading control. 5 μg of total protein from each lysate 
analyzed in (C) were also assayed for total DGK activity (D) using an in vitro assay (for details 
see Chapter 2.11).  Overexpression of mycDGKθ, but not mycDGKθ-kd, produced a significant 
increase in DGK activity compared to control (pRK5) neurons. (E) DGKθ KO neurons (DIV 20) 
expressing sypHy, mCherry, mycDGKθ-kd were stained with α-myc (red), GFP (green), and α-
dsRED (blue), merge panel (bottom). Together, data shown in (C-D) demonstrate that the failure 
of  mycDGKθ-kd to rescue SV recycling kinetics in DGKθ KO neurons is due to its lack of 
catalytic activity, and not altered expression level or subcellular targeting.   
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It is well known that the strength of the stimulus can activate distinct recycling 
mechanisms (16, 53). To determine if DGKθ is required for kinetically efficient SV 
recycling following elevated and mild neuronal activity, we evaluated the effect of the 
stimulation frequency and duration of stimulation on τendo in WT and KO neurons. 
Sustained stimulation at 10Hz and 50Hz resulted in significantly slower kinetics of SV 
endocytosis in KO neurons compared to WT (Figures 5.3A-5.3C). Interestingly, while 
higher frequency stimulation produced the largest change in endow between WT and KO 
neurons, we found that SV recycling kinetics became more impaired with increasing 
number of action potentials at both frequencies (Figures 5.3A-5.3C). Thus, we conclude 
from these data during periods of sustained neuronal activity, when more action 
potentials are fired, DGKθ plays a more critical role in promoting efficient retrieval of 
SVs.  
A potential consequence of reduced synaptic DGK activity found in DGKθ KO 
mice could be elevated levels of DAG in the plasma membrane. Since functional 
analogues of DAG are known to potentiate synaptic transmission (27), we hypothesized 
that the slowed recycling kinetics measured in DGKθ KO neurons could be the results of 
augmented SV exocytosis. To resolve the rate of SV exocytosis from the SV recycling 
dynamics reported by sypHy, WT and KO neurons were stimulated in the presence of the 
vesicular ATPase inhibitor, bafilomycin A1 (baf) (54). Baf blocks the reacidification of 
SVs without affecting recycling dynamics (55), thus SV exocytosis kinetics can be 
determined from the increase in fluorescence during neuronal stimulation. The rate of SV 
exocytosis measured in WT and KO neurons (Figure 5.4) were essentially identical. KO 
neurons did show a small increase in the maximum sypHy amplitude; however, this did 
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not reach statistical significance. Taken together, these data demonstrate that the SV 
recycling defect observed in DGKθ KO neurons is not secondary to altered exocytosis, 


















Figure 5.3. DGKθ promotes efficient recycling of SVs following elevated neuronal activity. 
(A) Comparison of the average endocytic time constants measured following 100 or 300 stimuli 
at 10 Hz. Averages are from ≥ 2 batches of WT and KO neurons, ≥3 coverslips, ≥200 boutons per 
condition.  For experiments shown in panels (A-C), data represent mean ± SEM; *** P < 0.001, 
ANOVA with Tukey’s post hoc test. (B) Comparison of the average endocytic time constants 
measured following 300 or 600 (from Figure 5.2) stimuli at 50 Hz. Averages are from ≥ 2 batches 
of WT and KO neurons, ≥3 coverslips, ≥120 boutons per condition. (C) Comparison of the 
average endocytic time constants measured following 300 stimuli at 10 Hz and 50 Hz shown in 









Figure 5.4.  SV exocytosis kinetics are normal in DGKθ KO neurons.  (A) Average traces of 
from WT and DGKθ KO neurons stimulated for 90 s at 10 Hz in the presence of 1 μM 
bafilomycin, a vesicular ATPase inhibitor. Traces were normalized to the average baseline before 
stimulation. Representative traces for each genotype are shown, averages shown are from one 
coverslip per genotype, >100 ROIs, data represent mean from ± SEM. (B) Average exocytic rate 
constants were determined by normalizing ΔF/F0 traces to the average maximum amplitude 
(average 10 frames after 90 s, 10 Hz stimulus). Tau values were calculated by fitting the rise-
portion of the response during stimulation to a one-phase association curve.  All averages in are 
from ≥ 3 batches of WT and KO neurons, ≥3 coverslips, ≥300 boutons per condition; data 
represent mean ± SEM. (C) Maximum amplitude of sypHy fluorescence response following a 90 
s stimulation at 10 Hz.  Values are calculated after normalization to baseline from ΔF/F0 curves 
(example of traces shown in (A). All averages in are from ≥ 3 batches of WT and KO neurons, ≥3 








CHAPTER 6.  
INSIGHTS INTO THE MECHANISM OF DGKΘ-




 Current research is focused on exploring the possible mechanism by which DGKθ 
catalytic activity promotes efficient recycling of SV following neuronal activity. To date, 
we have used three different approaches to gain insight into the mechanism (1) structure-
function analysis of DGKθ, (2) ultrastructure analysis of DGKθ WT and KO synapses, 
and (3) electrophysiological analysis of DGKθ WT and KO hippocampal slices. While 
these studies are still preliminary, recent experiments have produced some interesting and 
promising data, which are discussed below. Ongoing and future experiments that validate 
these findings will undoubtedly provide valuable insight regarding the mechanism behind 
the synaptic function of DGKθ, PtdOH and DAG.  
 
6.1  Structure-function analysis of DGKθ  
The finding that a kinase-dead mutant of DGKθ could not rescue the defects in 
SV recycling in DGKθ KO neurons indicates that the catalytic activity of the DGKθ is 
required for its role in promoting efficient retrieval of SVs following neuronal activity. 
These data, together with the total DGK activity and expression analysis of other DGK 
isoforms (Figure 5.1C-5.1D) suggests that it is unlikely that another DGK isoform is 
compensating for the loss of DGKθ in the KO mice. Since all DGK isoforms catalyze the 
same reaction, we were curious if any of the other structural components predicted by the 
primary amino acid sequence, particularly those that distinguish DGKθ from the other 
nine mammalian isoforms, were involved in specifying a role for DGKθ in SV recycling.  
Mammalian DGKs are classified into five subtypes based on similarities in their 
primary amino acid sequence (see Chapter 1.3). As the only type V DGK isoform, 
DGKθ protein structure is distinguished by the presence of three cysteine-rich domains 
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(CRDs, other DGK isoforms only have 2), a pleckstrin homology (PH) domain (also 
present in type II DGKs), a Ras-associating domain (RA) partially overlapping the PH 
domain, and an N-terminal proline/glycine-rich domain (PRD). To determine which 
structural features of DGKθ are required for its role in SV recycling, we generated a 
series of rationally designed DGKθ mutants that were truncated from either the N- or C-
terminus (T1-T6, Figure 6.1A). Western blot analysis using an antibody against the N-
terminal Myc-tag confirmed the expression of T1-T6 in HEK cells (Figures 6.1B-6.1D) 
and primary cortical neurons (Figures 6.1E-6.1F, respectively) by producing bands at 
the predicted molecular weights for each mutant. When the lysates were probed with a 
DGKθ antibody raised against an epitope containing the C-terminal region of human 
DGKθ (aa 691-820), all the mutants except for T1 and T2 were detected (Figures 6.1C 
and 6.1E). These results are expected as both T1 and T2 both contain large C-terminal 
truncations that removed the entire catalytic domain, which contains the epitope 
recognized by the antibody. Collectively, these data show that truncation of DGKθ does 



































Figure 6.1.  DGKθ truncation mutant proteins are stably expressed in HEK cells and 
primary neurons.  (A) Schematic of wild-type DGKθ protein domain structure (WT) compared 
to the DGKθ kinase-dead mutant (kd, G648A, position shown with red *) and six truncation 
mutants (T1-T6).  Residues deleted are shown on the right. WT and mutant DGKθ constructs 
were cloned into pRK5 and tagged at the N-terminus with Myc. PR, proline-rich domain; CRD, 
cysteine-rich domains (3 CRDs); extCRD, extended CRD; PH, pleckstrin homology domain, RA, 
ras-associated domain.  (B-D) Western blot analysis of HEK lysates transfected with either WT 
or mutant DGKθ using an antibody against the epitope tag (α-Myc (B) and (D) in green) and 
endogenous DGKθ ((C) α- DGKθ pAb and (D) red) that recognizes an epitope in the catalytic 
domain of DGKθ. WT and T3-T6 were recognized by both antibodies, but T1 and T2 were only 
recognized by α-Myc, which is expected since the catalytic domain was removed from these two 
mutants. (E-F) Western blot analysis of primary cortical neurons electroporated with WT and 
mutant DGKθ constructs shows these proteins are also stably expressed in neurons.  
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Previous studies have shown that DGKθ catalytic activity is sensitive to mutation 
and truncation(39). To measure DGK catalytic activity of our truncation mutants we 
assayed their activity in whole-cell lysates. For these experiments, lysates prepared from 
HEK cells transiently transfected with either WT DGKθ (positive control), DGKθ-kd 
(negative control) or DGKθ truncation mutants (T1-T6) were assayed in vitro for total 
DGK activity. Consistent with previous studies, expression of all but one truncation 
mutant (T6) in HEK cells did not produce a significant increase in DGK activity in 
lysates (Figure 6.2B). Interestingly, overexpression of T6, the smallest truncation mutant 
with only 25 amino acids removed from the N-terminus, produced a significant increase 
in DGK activity compared to control (empty vector, pRK5), similar to that measured in 
lysates expressing the full-length DGK enzyme. Similar experiments were performed in 
neurons (Figure 6.2C). Briefly, cortical neurons expressing WT DGKθ, DGKθ-kd or T1-
T6 were harvested at DIV 19, a time when endogenous DGKθ protein levels are high, 
and whole-cell lysates were assayed for DGK activity. While expression of DGKθ-kd or 
T1-T5 did not produce lysates with a significant increase in DGK activity over control 
(empty vector), lysates from neurons expressing WT DGKθ or T6 were significantly 
elevated for DGK activity (Figure 6.2C). Since DGKθ tends to aggregate during 
purification (unpublished observation), one possibility for the lack of activity is that the 
truncated enzyme is aggregated in cells. However, the stable expression of all the mutants 
in both HEK cells and neurons, as well as the uniform distribution of the mutants within 




























Figure 6.2.  DGKθ catalytic activity is high sensitive to mutation 
 (A) Schematic of wild-type DGKθ protein domain structure (WT) compared to the DGKθ 
kinase-dead mutant (kd, G648A, position shown with red *) and six truncation mutants (T1-T6).  
Residues deleted are shown on the right. (B-C) Total DGK activity was assayed in HEK (B) and 
neuronal (C) cell lysates shown in Figure 6.1. In both cell types, there was no significant 
difference in DGK activity measured in lysates expressing T1-T5 or DGKθ-kd compared to 
control. Expression of WT DGKθ or T6 resulted in a significant increase in total DGK activity. 




Given our ability to express truncation mutants, we were curious to determine 
whether they affected DGKθ subcellular localization or neuronal morphology. For this 
study, , hippocampal neurons were transiently transfected with WT DGKθ, DGKθ-kd or 
T1-T6, along with sypHy, to identify synapses, and dsRed, to examine the cell 
morphology. Preliminary analysis of neurons labeled with antibodies against the Myc 
(DGKθ) and GFP (sypHy) epitope tags revealed significant overlap between the two 
signals along neuronal processes for WT DGKθ (Figure 6.2B) and all DGKθ mutants 
(Figure 6.2C) except T3 and T4 (Figure 6.2D). While these findings still need to be 
confirmed, they suggest that truncation of DGKθ does not significantly alter subcellular 
targeting of the enzyme. Of note, the cell morphology of neurons expressing the 
truncated WT DGKθ mutants did appear abnormal, albeit with extra branching along 
axons/dendrites as well as neurite-like protrusions from the neuronal processes (Figures 
6.2C-6.2D). Future studies examining the effect of these mutants on spine development 
and neuronal morphology are necessary to determine and classify the mutant 





































Figure 6.3.  Synaptic localization of DGKθ truncation mutants  
(A) Schematic of wild-type DGKθ protein domain structure (WT) compared to the DGKθ kinase-
dead mutant (kd, G648A, position shown with red *) and six truncation mutants (T1-T6).  
Residues deleted are shown on the right. (B-D) Hippocampal neurons were transiently transfected 
with WT DGKθ, DGKθ-kd or T1-T6 (blue), along with sypHy (green), to identify synapses, and 
dsRed (red), to examine the cell morphology. (B) WT DGKθ, DGKθ-kd and (C) T1, T2, T5, and 
T6 localize with sypHy on axons.  (D) T3 and T4 show more diffuse localization in the soma and 
neuronal processes, and do not show strong overlap with sypHy.  More experiments are necessary 
to confirm and quantify these observations.   
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T6, the only mutant that exhibited WT DGKθ activity in both HEK cells and 
neurons is of particular interest as it is not only catalytically active, but the 25 amino 
acids that are absent from this mutant enzyme encode a putative Src-homology (SH3) 
domain within the N-terminal PRD (43). Numerous endocytic adaptor proteins, with 
established roles in SV recycling, are known to interact with dynamin 1 through binding 
of their SH3 domains with the PRD on dynamin (56).  This is particularly interesting as 
dynamin 1 is abundant in neuronal tissue and known which plays an essential role in the 
fission reaction during clathrin-dependent and clathrin independent endocytosis of SVs 
(57-59). We therefore considered a few potential mechanisms-that are not mutually 
exclusive for how DGKθ is regulating the kinetics of SV endocytosis: 
1) DGKθ production of PtdOH recruits (and activates) endocytic adaptor 
proteins and/or dynamin 1 to endocytic sites 
2) DGKθ directly interacts with endocytic adaptor proteins/dynamin 1, 
these interactions modulate DGKθ activity, leading to changes in 
PtdOH production #1 or for regeneration of PtdIns 
If endogenous DGKθ activity is regulated by an endocytic protein via binding to its N-
terminus, the T6 mutant should not be able to rescue the SV defect in DGKθ KO neurons. 
On going experiments testing the ability of this mutant to rescue the defect in SV 
recycling in DGKθ KO neurons will provide important insight into the potential 
mechanism for how DGKθ is regulating SV recycling 
6.2  Ultrastructural analysis of DGKθ KO synapses 
To further investigate how the loss of DGKθ results in defective SV retrieval 
following neuronal activity, we used electron microscopy to perform ultrastructural 
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analyses of neuronal synapses from wild type or DGKθ KO mice. The high resolution of 
this methodology has can be used to characterize SVs within the presynaptic bouton 
(size, number, distance to the active zone), as well as reveal structural abnormalities 
(endocytic intermediates, stranded SVs, clathrin coated SVs, etc.) that could explain the 
defects in SV recycling in DGKθ mice (60, 61). For these experiments, we first examined 
the synaptic structure of CA1 pyramidal synapses in the hippocampi of WT and DGKθ 
KO mice. There were two obvious differences in DGKθ KO synapses compared to WT. 
First, DGKθ KO synapses have more SVs compared to WT (Figures 6.4A-6.4B). While 
this observation appears to be inconsistent with the sypHy data that showed no difference 
SV pool size (Figure 5.4), it could be explained by the second notable difference at 
DGKθ KO synapses, the distribution and localization of the SVs. There is a notable 
difference in the number of SVs in each electron micrograph of DGKθ KO slices, 
however, several of these SVs were not associated with a conventional synaptic structure, 
presynaptic bouton opposite to postsynaptic terminal with a prominent PSD (Figures 
6.4A-6.4B). One possible explanation for the possible redistribution of SVs could be 
altered DAG levels in synaptic and extra-synaptic membranes. Since DAG is known to 
stimulate the priming activity of Munc13-1, and DGKθ is localized to many subcellular 
regions, it is possible that DAG levels are elevated throughout DGKθ KO neurons, 
leading to the mislocalization of synaptic proteins and SVs. At some DGKθ KO 
synapses, we observed tethers between SVs that were not immediately adjacent to the 
presynaptic membrane (Figure 6.4A-6.4B), which could reflect an endocytic 
intermediate or defective SV priming.  
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While these results still need to be confirmed, we are encouraged by preliminary 
ultrastructural analysis of synapses from neuronal cultures derived from WT and DGKθ 
KO mice (Figures 6.5). Examination of synapses from 2-3 week-old cultures of primary 
neurons revealed similar differences in the number and distribution of SVs in DGKθ KO 
neurons compared to WT (Figures 6.5A-6.5B). A third, less obvious, difference detected 
at KO synapses in cultured neurons was the presence of membrane invagination at the 
presynaptic plasma membrane (Figures 6.5A-6.5B), which could reflect the slower 
reuptake of SVs during basal neurotransmission. Ongoing research in the laboratory is 
focused on further analysis and quantification of the differences in SV size, distribution, 
and membrane dynamics between WT and DGKθ KO synapses. Nevertheless, there is an 
obvious phenotype in DGKθ KO synapses, which has been observed now in two different 

































Figure 6.4. Loss of DGKθ activity produces changes in the number and localization of SVs 
in CA1 neurons.   (A-B)  Top and middle, electron micrographs of two representative synapses 
from neurons in the CA1 region of wild-type (WT) and DGKθ KO hippocampal sections. 
Ultrastructural analysis of DGKθ KO tissue showed increased number of SVs as well as clusters 
of SVs at non-synaptic sites (red arrows). Lower panel, higher magnification view of WT and KO 
synapses (red box, middle panel) reveals tethers between SVs ~100nm away from the plasma 
membrane at KO synapses (red arrow) but not WT synapses. SV-tethers were are a less common 
phenotype found in KO electron micrographs and were not observed at all KO synapses. While 
these data required further quantitative validation, the phenotype was observed at the majority of 
synapses examined (>40 for each genotype) from two different pairs of aged-matched WT and 



























Figure 6.5. Ultrastructural changes in SV number and distribution are also observed in 
cultured cortical neurons derived from DGKθ KO animals.  (A-B)  Top panel, electron 
micrographs of WT and DGKθ KO synapses from primary cortical neurons (DIV 15). 
Ultrastructural analysis of DGKθ KO synapses from culture neurons showed a similar phenotype 
to that observed in CA1 neurons from hippocampal slices. Lower panel, high magnification view 
of KO synapses revealed membrane invaginations (red arrow, observed 3 times in KO, 1 time in 
WT micrographs). These data required further quantitative validation to confirm the apparent 
phenotype observed in KO neurons. Representative images for each genotype were selected from 
>40 synapses examined, from three different batches of cultured neurons (DIV 15-21). Scale bar, 
100 nm.  
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6.3  Electrophysiological properties of DGKθ KO mice  
These experiments were done in collaboration with Dr. Lenora Volk currently at the 
University of Texas-Southwestern, Department of Neuroscience 
Since DGKθ colocalizes with vGlut1 at presynaptic glutamatergic terminals of 
hippocampal neurons in vitro and affects SV recycling (Figures 3.2, 4.2, 5.2), we 
considered the possibility that DGKθ regulates excitatory synaptic transmission. To test 
this hypothesis, we examined excitatory synaptic function in WT and DGKθ KO mice by 
stimulating the glutamatergic terminals of CA3 neurons (Schaffer collaterals, SC), which 
project onto excitatory pyramidal cells and inhibitory interneurons of the CA1 area. Loss 
of DGKθ is predicted to produce elevated DAG levels, which has been shown to increase 
SV release probability(32, 37) . While we did not observe any change in SV exocytosis in 
DGKθ KO neurons using the sypHy reporter (Figure 5.4), we speculated that this assay 
may not be sensitive or fast enough to pick up a small change in SV release probability. 
Therefore, we compared paired-pulse facilitation (PPF), an established measure of basal 
SV release probability at SC-CA1 WT and DGKθ KO synapses. At all inter-stimulus 
intervals (ISI), we observed slightly increased PPF in DGKθ KO slices, compared to 
slices prepared from WT animals (Figure 6.6A), suggesting that SV release is slightly 
impaired. However, these results did not achieve significance (P = 0.13, genotype effect, 
two-way repeated measures ANOVA; n = 14/group) and the effect of ISI did not differ 
between genotypes (P=0.64, interaction effect, two-way repeated measures ANOVA). 
More experiments are necessary to determine if this trend towards increased PPF is real, 
especially at shorter ISI (25-50 ms).  
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To test the role of DGKθ in modulating excitatory drive specifically onto 
excitatory neurons, we measured PPF at SC-CA1 synapses when inhibitory transmission 
was blocked with picrotoxin, a GABAA-receptor antagonist. Interestingly, DGKθ KO 
synapses showed slightly decreased PPF at all ISI (Figure 6.6B) (P = 0.09, genotype 
effect, two-way repeated measures ANOVA; n = 10 WT, n = 11 KO). We observed the 
most significant difference at the smallest ISI (P = 0.07, interaction effect of ISI and 
genotype, two-way repeated measures ANOVA; P<0.05 at 25 ms, post hoc Bonferroni 
test).  
Lower paired-pulse ratios (PPR) values, as we observed in the presence of 
picrotoxin, are usually indicative of an increased basal SV release probability. These 
results could suggest that excitatory drive onto excitatory neurons is slightly increased. 
However, PPR values measured at short ISI (25 and 50 ms) in the presence of picrotoxin 
induce recurrent activity during the second pulse. Therefore, a decrease in the ratio of the 
fEPSPs (response 2/ response 1) observed at DGKθ KO synapses might not actually 
reflect a change in the calcium-induced facilitation but rather a decrease in the recurrent 
activity induced in the second pulse. Qualitative comparison of recurrent activity induced 
during the second pulse of PPF measured at short ISIs showed that DGKθ KO synapses 
displayed less recurrent activity compared to WT (Figure 6.6B, 50 ms interval, red 
arrow). While these data require further quantitative confirmation, it is intriguing that loss 
of DGKθ produces opposite, and unequal effects on PPF in the presence and absence of 
picrotoxin. These opposing trends in the data suggest that DGKθ modulates excitatory 

























Figure 6.6.  Acute slices from DGKθ KO mice display lower recurrent activity.  
Paired pulse facilitation (PPF) was assayed in acute hippocampal slices from WT and DGKθ KO 
mice in the absence (A) and presence (B) of picrotoxin (PTX). Top, the ratios of the paired-pulse 
response (fEPSP slope response 2 / fEPSP slope response 1) were plotted against the inter-
stimulus intervals (in milliseconds, msec). Without PTX, when excitatory and inhibitory 
transmission is intact, PPF was not significantly different in DGKθ KO slices compared to WT 
(WT n=14, KO n=14; p > 0.05 at all inter-stimulus intervals, two-way repeated measures 
ANOVA with Bonferroni post hoc test). When PPF was assayed in the presence of 100 μM PTX 
(only excitatory transmission is intact, inhibitory transmission is blocked), DGKθ KO slices 
showed a significant decrease in facilitation with the shortest (25 msec) inter-stimulus interval 
(WT n=11, KO n=10; p < 0.05). Bottom, representative synaptic responses generated by a paired-
pulse with a 50 msec inter-stimulus interval.  KO slices showed less recurrent activity (red arrow) 
compared to WT during the second pulse.  fEPSP – field excitatory postsynaptic potential.   
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Previous studies have shown that defects in SV recycling alter synaptic 
transmission by affecting the ability of the neurons to maintain neurotransmitter release 
during sustained neuronal activity (18, 60, 62, 63). Since DGKθ KO neurons showed 
defect in SV retrieval following elevated neuronal activity (Figure 5.3), we speculated 
that evoked transmission could be attenuated in acute slices. To address this, we recorded 
field excitatory postsynaptic potentials (fEPSP) during a high frequency stimulus train 
(900 stimuli delivered at 50 Hz) in acute slices from WT and DGKθ KO SC-CA1 
neurons. This stimulation successfully depressed synaptic transmission in both WT and 
KO synapses (Figure 6.7A). Comparison of the fEPSP amplitudes at the beginning (0-
0.8 s) and end (17.6-18s) of the 50 Hz train with a two-way repeated measure ANOVA 
showed no significant difference between the two genotypes (P0-0.4s = 0.55, n = 12/both; 
P17.6-18s = 0.80, WT n = 10, KO n = 11, genotype effect, Figures 6.7Ai-ii).  
Since blockade of inhibitory transmission revealed a significant change in PPF in 
DGKθ KO slices, we speculated that the rate or amount of synaptic depression might also 
be affected in in the presence of picrotoxin compared to WT. Consistent with PPRs 
measured in the presence of picrotoxin (Figure 6.6B), DGKθ KO synapses exhibited a 
trend toward lower fEPSP amplitudes at the beginning of the 50 Hz train compared to 
WT (P0-08s = 0.33, genotype effect, two way repeated measured ANOVA, WT n = 10, KO 
n = 9, Figure 6.7Ai). A similar trend towards lower fEPSP amplitudes was also observed 
at the end of the 50 Hz train at DGKθ KO synapses, however, this is likely not relevant 
since the synaptic responses at the end of the depleting stimulus train are very small and 
difficult to distinguish over the background electrical noise ( (P17.3-17.98s = 0.11, genotype 
effect, WT n = 16, KO n = 12, Figure 6.7Aii). 
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Defects in SV recycling have also been shown to effect synaptic recovery 
following high frequency transmission (60, 64, 65). Despite showing no significant 
difference in the rate or degree of synaptic depression during the 50 Hz train, we 
speculated that DGKθ KO synapses might have altered synaptic transmission during the 
recovery period after the stimulus train is given. To address this, we measured field 
potentials at 2 Hz immediately following delivery of the depletion stimulus (900 AP, 50 
Hz) in the presence and absence of picrotoxin. When excitatory and inhibitory 
transmission was intact (no picrotoxin), we measured a small decrease in the fEPSP 
amplitude of the first response measured at 2 Hz immediately following the 50 Hz train at 
DGKθ KO synapses compared to WT (Figure 6.8B). A two-tailed student’s t test 
analysis of this first response found this decrease in fEPSP amplitude in DGKθ KO slices 
to be significant (P = 0.037, WT n = 12, KO n = 12). However, two-way repeated 
measure ANOVA shows that there is a significant effect of time on fEPSP amplitudes 
during the recovery (P < 0.001, time effect, n = 12/group). Therefore, while the student’s 
t test is encouraging that this trend might be real (more experiments are necessary to 
validate this), is not an accurate measure of significance. When we used a repeated 
measures two-way ANOVA to compare of the first four responses of the 2 Hz recovery 
we found no significant difference in the fEPSP amplitudes between WT and DGKθ KO 
slices (P = 0.176, genotype effect, n = 12/group). While we currently lack enough data to 
form a firm conclusion of these data, the small decrease in fEPSP amplitude observed 
during the first response of the 2 Hz recovery is consistent with the defect in SV 
recycling measured at DGKθ KO synapses. When we repeated these experiments in the 
presence of picrotoxin, we observed an opposite trend in fEPSP amplitudes during the 
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first four responses of the 2 Hz recovery period (Figure 6.7B). DGKθ KO synapses 
showed slightly larger responses to the second and third recovery stimuli compared to 
WT, however, this difference did not reach statistical significance (P = 0. 116, genotype 





































Figure 6.7. DGKθ KO mice show a small trend toward impaired synaptic recovery 
following high frequency stimulation.  (A) Average amplitudes of fEPSPs measured in acute 
slices from WT and DGKθ KO mice during a high frequency stimulus train (900 stimuli, 50 Hz) 
were plotted against time (s). Responses from each slice were normalized to the peak fEPSP 
amplitude in the train. Top panel, average fEPSPs measured over the entire 50 Hz train in the 
absence (left) and presence (right) of 100 μM picrotoxin (PTX). Detailed view of fEPSPs during 
the beginning (i) and end (ii) of the stimulus train are shown below. Two-way repeated measures 
ANOVA with Bonferroni post hoc test found no significant difference between WT and DGKθ 
KO fEPSP amplitudes measured in the presence or absence of PTX (p > 0.05 interaction effect 
and at all time points, P values reported in text). (B) Synaptic recovery was probed in WT and 
DGKθ KO slices at 2 Hz (arrow) immediately following the 50 Hz stimulus train in the presence 
(right) and absence (left) of PTX. Two-way repeated measures ANOVA with Bonferroni post hoc 
test found no significant difference in recovery between WT and DGKθ KO (p > 0.05 at all 
individual time points, +/- PTX, summary P values reported in text).   
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While these data are complicated to interpret, together they demonstrate trends in 
altered transmission in DGKθ KO animals that could be explained by several different 
mechanisms. One possibility for the opposing DGKθ KO transmission phenotypes 
measured in the presence or absence of picrotoxin could be that DGKθ acts at 
glutamatergic synapses projecting onto both excitatory and inhibitory neurons. In the 
absence of DGKθ, glutamatergic drive from CA3 SC is decreased onto both CA1 
pyramidal neurons and CA1 interneurons, meaning that overall synaptic transmission 
appears mostly intact. When inhibitory transmission is blocked with picrotoxin, the 
decreased excitatory drive onto excitatory neurons is revealed. While more experiments 
are necessary to provide data to support this hypothesis, analysis of the input-output data 
(I-O curves) already acquired during experiment’s discussed here could be informative 
and should be explored in the future. 
There are several possible explanations for the observed decrease in recurrent 
activity observed at KO SC-CA1 synapses: change in connectivity, difference in the 
number of synapses, number of excitatory and inhibitory synapses (E/I balance), or 
change in intrinsic excitability of the neurons. Many interesting questions emerge form 
these experiments. Is the altered recurrent activity in DGKθ KO animals a product of 
defective SV recycling over the course of development? Or is this a separate phenotype 
in the DGKθ KO mince due additional roles for DGKθ in neuronal tissue? Future 
experiments addressing these questions will help specify the physiologic role for DGKθ 












Despite speculations regarding the roles of mammalian DGKs in modulating 
synaptic function, the function of DGKθ in the brain has remained unknown. The data 
presented in this thesis were designed to test the hypothesis that DGKθ modulates 
neurotransmitter release from central synapses. I found that DGKθ protein expression is 
coincident with synaptogenesis and localizes specifically to excitatory synapses. Both 
acute and chronic loss of DGKθ from cortical neurons resulted in slowed SV retrieval 
following neuronal stimulation. SV recycling kinetics could be rescued by ectopic 
expression of enzymatically active, but not inactive, DGKθ, thus, implicating DGKθ 
catalytic activity in promoting the efficient recycling of SVs following neuronal activity.  
7.1 DAG, DGKs and SV exocytosis 
DGKs catalyze the conversion of DAG to PtdOH, thus, depletion of DGKθ is 
predicted to increase DAG levels, a lipid that has an established role in promoting SV 
exocytosis. This was observed in C. elegans, where loss of function mutation in the 
DGKθ homolog, DGK-1, produced elevated DAG which enhanced UNC13-mediated NT 
release from NMJ (37). Therefore, we were surprised when we found that depletion of 
DGKθ attenuated glutamate release from cortical neurons with no measurable change in 
the size of the recycling pool of SVs or the rate of SV exocytosis (Figure 5.4). While we 
have yet to measure synaptic DAG/PtdOH levels in DGKθ KO tissue, our studies 
indicate that DGKθ may not be the enzyme responsible for metabolizing DAG used for 
SV exocytosis, but rather may play a more important role in producing PtdOH used for 
SV retrieval.  
If DGKθ is not the enzyme that clears exocytic pools of DAG, how is this lipid 
metabolized? Of the DGK isoforms found at excitatory presynaptic terminals, DGKι is 
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the mostly likely candidate for this role. DGKι is one of two type IV DGKs, localized to 
both pre- and postsynaptic sides of excitatory and inhibitory synapses, and is the only 
other DGK that has been shown to regulate a presynaptic function (32). Yang et al. found 
that DGKι knock-out mice displayed small increase in presynaptic release probability and 
a reduction in mGluR-LTD in young mice at an age when this processes is regulated by 
the presynaptic terminal (~2 weeks). While these findings implicate DGKι in the 
regulation of SV exocytosis, the activity of this isoform, alone, may not fully account for 
DAG-mediated potentiation of NT release, as loss of DGKι did not produce a significant 
change in PDBu-dependent potentiation of presynaptic release compared to WT 
animals(32). Previous work has shown that different signaling pathways are employed to 
enhance neurotransmission depending on the duration of PDBu treatment (27, 66) prior 
to the stimulus. Both loss-of-function studies on DGKι and DGKθ have been performed 
in animals from a conventional KO background. If the prediction is correct and loss of 
DGK produces elevated DAG levels, both DGKι and DGKθ KO animals should have 
chronically elevated DAG levels during neurodevelopment and synaptogenesis. Thus, the 
stimulatory effect of PDBu will likely be different in these animals than those reported in 
WT backgrounds. Furthermore, loss of one DGK might be insufficient to elevate 
endogenous DAG levels those mimicked by PDBu-treatment. Future studies examining 
the effects of loss of two presynaptic kinases (DGKθ and DGKι) on presynaptic function 
will be very informative regarding the functional interaction and potential redundancy of 
these enzymes within a single subcellular compartment.  
More work is needed to elucidate the precise role of DGKs in SV recycling during 
excitatory synaptic transmission. It is possible that DGKθ, DGKι, and other presynaptic 
 75 
DGKs may have different activities depending on the strength and duration of the 
stimulus. Studies comparing SV recycling kinetics in DGKθ, DGKι, or both enzymes on 
SV cycling kinetics during various types of synaptic transmission roles will be 
informative.  
With multiple DGK isoforms acting within the presynaptic terminal, it is unlikely 
that they are regulating one common pool DAG/PtdOH. Rather, we propose that DGKθ, 
DGKι, and other presynaptic DGKs are regulating distinct pools of these signaling lipids. 
Since SV exo- and endocytosis occur at spatially segregated sites within the bouton, we 
would predict that DGKι regulates DAG/PtdOH inside the active zone, at sites 
corresponding to vesicle release, and DGKθ regulates these lipids at adjacent regions 
(periactive zone) corresponding to sites of vesicle retrieval and endocytosis. Recent 
advances in microscopy techniques using super-resolution imaging, will likely permit the 
visualization of the dynamics of these individual lipid domains within the presynaptic 
membrane, in live cells. 
The possibility that increases in one of the seven other neuronal DGK isoforms 
may compensate for the loss of DGKθ has not been completely ruled out. However, we 
were able to measure a significant reduction in DGK activity measured in DGKθ KO 
brain tissue and no change in protein expression of other DGK isoforms (Figure 5C). 
These data strongly argue against the notion that other DGK isoforms compensate for the 
loss DGKθ, and favor the idea that DGKθ plays a unique role in endocytosis. Future 
studies specifying the roles for other DGKs in SV recycling will provide further insight 
into the distinct or redundant roles of DGKs in presynaptic function. 
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7.2 DGKθ and PtdOH may regulate multiple endocytic retrieval pathways 
If DGKθ is regulating a distinct pool of DAG that does not mediate SV 
exocytosis, it raises the intriguing possibility that it is the PtdOH produced by DGKθ, 
rather than its consumption of DAG, that is mediating its role in SV recycling. Two 
major pathways currently recognized to retrieve SVs from the plasma membrane in 
central nerve terminals are clathrin-mediated endocytosis (CME) and activity-dependent 
bulk endocytosis (ADBE). DGKθ appears to play a more critical role in promoting 
efficient retrieval of SVs during periods of sustained neuronal activity, when more action 
potentials are fired (Figure 5.3). As ADBE is the dominant mechanism of SV retrieval 
during periods of intense neuronal activity, it is possible that DGKθ-mediated PtdOH 
production is involved in regulating ADBE. However, a recent unpublished study found 
that sypHy only reports on CME, not ADBE (unpublished observation, J.C. Nicholson-
Fish et al. SFN 2014). It is clear, therefore, that we cannot exclude the possibility that 
DGKθ regulates ADBE and more experiments are necessary to place DGKθ in this 
pathway. SV recycling assays using FM1-43 and FM2-10 or the new pHluorin construct 
that does report on ADBE (unpublished observation, J.C. Nicholson-Fish et al. SFN 
2014), will be critical to refine the signaling pathways regulated by DGKθ.  
CME is the dominant mechanism of SV retrieval during mild neuronal activity 
and in such, is thought to be the dominant pathway employed during most modes of 
synaptic transmission in vivo (11, 16, 53). Since SV recycling kinetics were measured 
using sypHy, we may conclude that CME is slower in DGKθ KO neurons. Consistent 
with these data, previous studies in non-neuronal cells have shown that PtdOH 
production by DGKs is important for CME (30, 67, 68). However, DGK-mediated 
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PtdOH production has yet to be implicated in CME at central synapses. These studies, 
together with the data presented in this thesis, which demonstrate that DGKθ catalytic 
activity is required for its regulation of SV recycling, are the first to implicate DGKθ-
mediated production of PtdOH in clathrin-mediated endocytosis of SVs. 
While it is still unknown which proteins interact with DGKθ at synapses, previous 
studies in non-neuronal cells as well as in vitro, have shown that the small GTPase, 
RhoA, binds to DGKθ and inhibits its catalytic activity (39, 44). Other DGK isoforms 
have been shown to interact with clathrin adaptors via conserved protein domains found 
in all DGK family members (67, 68). Further studies are needed to elucidate the 
mechanisms by which DGKθ and possibly its production of PtdOH modulates the 
kinetics of SV recycling. 
7.3 DGKθ, PtdOH, and synaptic PtdIns cycle  
PtdOH is known to stimulate the activity of PIPK1γ, the major enzyme 
responsible for synaptic PtdIns(4,5)P2 production (63, 69). PtdIns(4,5)P2 acts as an anchor 
for endocytic machinery in the synaptic plasma membrane (2, 20, 68). In addition to its 
regulation of PIPK1γ activity, PtdOH is also known to stimulate the activity of dynamin, 
the large GTPase responsible for pinching off internalized SVs (20, 21). Thus, the 
reduction of DGKθ activity measured in KO tissue could result in a decrease in synaptic 
PtdOH, and, subsequently a reduction in PtdIns(4,5)P2, leading to impaired recruitment 
of endocytic machinery and slowed SV endocytosis. Future studies elucidating the role of 
PtdOH in this cycle are necessary to determine if PtdOH is required primarily for PtdIns 
synthesis or as allosteric activator of PIPK1γ, dynamin I or other endocytic proteins that 
have an affinity for acidic phospholipids.  
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7.4  DGKs regulation of cellular trafficking in non-neuronal cells 
DGKθ is not the first DGK to be implicated in regulating cellular trafficking and 
clathrin-mediated endocytosis. In non-neuronal cells, DGKζ and DGKδ have been shown 
to interact with CME adaptor proteins and thereby modulating receptor internalization 
and recycling (67, 68, 70). Interestingly, kinase-independent functions of DGKζ have 
been reported for this isoform in neuronal outgrowth (71). These studies together with 
our data suggest that DGK-modulation of membrane trafficking at neuronal synapses 
may be two-fold-(1) through catalytically-dependent DAG metabolism and (2) through 
catalytically-independent modulation of adaptor functions. DGKθ could be a good model 
to elucidate the adaptor functions of DGKs in cellular trafficking from the catalytic 
functions because, as mentioned previously, its catalytic activity is highly sensitive to 
mutations or truncations and it has multiple adaptor domains (39). While we show that 
DGKθ activity is required for its regulation of SV recycling, the abundance of protein-
protein and protein-lipid domains in its primary amino acid sequence suggest that it could 
employ additional adaptor functions. As discussed above, many proteins involved in SV 
retrieval interact with one another via SH3 domains (Chapter 6.1) (56). If DGKθ is 
interacting with the endocytic machinery via its PRD or putative SH3-domain within the 
PRD, we would predict that the T6 truncation mutant, missing the N-terminal aa1-25 but 
with full catalytic activity, may not be able to recovery the defect in SV recycling 
observed in DGKθ KO neurons. Future experiments testing this hypothesis, as well as 
identifying endogenous interacting partners of DGKθ will provide valuable insight 
regarding the molecular mechanism behind DGKθ regulation of SV recycling.  
 79 
Final remarks 
While the balance of activity-induced SV exo- and endocytic processes is 
necessary to support synaptic transmission (6, 13), recent work has shown that 
uncoupling of these two processes does not result in absolute failure of the opposing 
process (72-74). With nine DGK isoforms found in neuronal tissue in addition to the PLD 
family of enzymes, there are many possible routes available to neurons to ensure proper 
regulation of PtdOH, and, subsequently, PtdIns lipids in synaptic membranes. These data, 
together with our data showing opposing effects of picrotoxin on excitatory transmission 
in DGKθ KO slices suggest that neuronal signaling defects resulting from loss of DGKθ 
activity are balanced in the CNS. Thus, I hypothesize that the ability of the nervous 
system to compensate for such critical pathways, such as those mediating changes in 
neuronal lipid metabolism, is vital for the normal nervous system function and protection 
from of disease and dysfunction. Future experiments that assess alternative physiological 
deficits in DGKθ animals as well as behavioral outcomes will be exciting to pursue and 
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